Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03673124
Title Ribociclib and Letrozole Treatment in Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Gynecologic Oncology Group

ovarian serous carcinoma

peritoneal carcinoma


Letrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.